Skip to main content

Pharmacokinetics of intravenous (IV) and oral (PO) idarubicin (4DMDR) in children with cancer

Publication ,  Journal Article
Hancock, C; Bacha, D; Niedzwiecki, D
Published in: Proceedings of the American Association for Cancer Research
January 1, 1985

Duke Scholars

Published In

Proceedings of the American Association for Cancer Research

Publication Date

January 1, 1985

Volume

VOL. 26
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hancock, C., Bacha, D., & Niedzwiecki, D. (1985). Pharmacokinetics of intravenous (IV) and oral (PO) idarubicin (4DMDR) in children with cancer. Proceedings of the American Association for Cancer Research, VOL. 26.
Hancock, C., D. Bacha, and D. Niedzwiecki. “Pharmacokinetics of intravenous (IV) and oral (PO) idarubicin (4DMDR) in children with cancer.” Proceedings of the American Association for Cancer Research VOL. 26 (January 1, 1985).
Hancock C, Bacha D, Niedzwiecki D. Pharmacokinetics of intravenous (IV) and oral (PO) idarubicin (4DMDR) in children with cancer. Proceedings of the American Association for Cancer Research. 1985 Jan 1;VOL. 26.
Hancock, C., et al. “Pharmacokinetics of intravenous (IV) and oral (PO) idarubicin (4DMDR) in children with cancer.” Proceedings of the American Association for Cancer Research, vol. VOL. 26, Jan. 1985.
Hancock C, Bacha D, Niedzwiecki D. Pharmacokinetics of intravenous (IV) and oral (PO) idarubicin (4DMDR) in children with cancer. Proceedings of the American Association for Cancer Research. 1985 Jan 1;VOL. 26.

Published In

Proceedings of the American Association for Cancer Research

Publication Date

January 1, 1985

Volume

VOL. 26